Reimbursement data shows a marked increase in spending in Q3 and Q4 , likely due to more aggressive prescribing for weight loss: Q1 2024: ~$65M Q2 2024: ~$70M Q3 2024: ~$170M Q4 2024: ~$190M Unlike Ozempic, Wegovy reimbursements were more evenly distributed across dosage levels , from 0.25mg up to the full 2.4mg dose
The most common is 1,000 mcg per mL, used for injections
These applications often include pattern recognition features that identify trends and provide insights into factors affecting glycaemic control
One of the most discussed side effects is dizziness
Convenient Administration: Comes in a pre-mixed formulation, removing the need for reconstitution and simplifying the dosing process
La molcula est aprobada por la FDA para uso en obesidad, pero todava en nuestro pas no tiene esa indicacin